These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 31442005)

  • 1. Side Chain Orientation of Tryptophan Analogues Determines Agonism and Inverse Agonism in Short Ghrelin Peptides.
    Nicke L; Müller R; Geyer A; Els-Heindl S
    ChemMedChem; 2019 Nov; 14(21):1849-1855. PubMed ID: 31442005
    [TBL] [Abstract][Full Text] [Related]  

  • 2. C-terminus of a hexapeptidic ghrelin receptor inverse agonist can switch peptide behavior from inverse agonism to agonism.
    Els-Heindl S; Bellmann-Sickert K; Beck-Sickinger AG
    Biopolymers; 2016 Jan; 106(1):101-8. PubMed ID: 26566778
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An aromatic region to induce a switch between agonism and inverse agonism at the ghrelin receptor.
    Els S; Schild E; Petersen PS; Kilian TM; Mokrosinski J; Frimurer TM; Chollet C; Schwartz TW; Holst B; Beck-Sickinger AG
    J Med Chem; 2012 Sep; 55(17):7437-49. PubMed ID: 22920150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tryptophan Analogues with Fixed Side-Chain Orientation: Expanding the Scope.
    Nicke L; Horx P; Müller R; Els-Heindl S; Geyer A
    Chembiochem; 2021 Jan; 22(2):330-335. PubMed ID: 33463878
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design, evaluation, and comparison of ghrelin receptor agonists and inverse agonists as suitable radiotracers for PET imaging.
    Chollet C; Bergmann R; Pietzsch J; Beck-Sickinger AG
    Bioconjug Chem; 2012 Apr; 23(4):771-84. PubMed ID: 22372770
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of an efficacy switch region in the ghrelin receptor responsible for interchange between agonism and inverse agonism.
    Holst B; Mokrosinski J; Lang M; Brandt E; Nygaard R; Frimurer TM; Beck-Sickinger AG; Schwartz TW
    J Biol Chem; 2007 May; 282(21):15799-811. PubMed ID: 17371869
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of the constitutive activity of the ghrelin receptor by use of pharmacological tools and mutagenesis.
    Mokrosiński J; Holst B
    Methods Enzymol; 2010; 484():53-73. PubMed ID: 21036226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unique interaction pattern for a functionally biased ghrelin receptor agonist.
    Sivertsen B; Lang M; Frimurer TM; Holliday ND; Bach A; Els S; Engelstoft MS; Petersen PS; Madsen AN; Schwartz TW; Beck-Sickinger AG; Holst B
    J Biol Chem; 2011 Jun; 286(23):20845-60. PubMed ID: 21402696
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ghrelin receptor inverse agonists: identification of an active peptide core and its interaction epitopes on the receptor.
    Holst B; Lang M; Brandt E; Bach A; Howard A; Frimurer TM; Beck-Sickinger A; Schwartz TW
    Mol Pharmacol; 2006 Sep; 70(3):936-46. PubMed ID: 16798937
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular mechanism of agonism and inverse agonism in ghrelin receptor.
    Qin J; Cai Y; Xu Z; Ming Q; Ji SY; Wu C; Zhang H; Mao C; Shen DD; Hirata K; Ma Y; Yan W; Zhang Y; Shao Z
    Nat Commun; 2022 Jan; 13(1):300. PubMed ID: 35027551
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New ligands of the ghrelin receptor based on the 1,2,4-triazole scaffold by introduction of a second chiral center.
    Maingot M; Blayo AL; Denoyelle S; M'Kadmi C; Damian M; Mary S; Gagne D; Sanchez P; Aicher B; Schmidt P; Müller G; Teifel M; Günther E; Marie J; Banères JL; Martinez J; Fehrentz JA
    Bioorg Med Chem Lett; 2016 May; 26(10):2408-2412. PubMed ID: 27072910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overlapping binding site for the endogenous agonist, small-molecule agonists, and ago-allosteric modulators on the ghrelin receptor.
    Holst B; Frimurer TM; Mokrosinski J; Halkjaer T; Cullberg KB; Underwood CR; Schwartz TW
    Mol Pharmacol; 2009 Jan; 75(1):44-59. PubMed ID: 18923064
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification, optimization, and pharmacology of acylurea GHS-R1a inverse agonists.
    McCoull W; Barton P; Brown AJ; Bowker SS; Cameron J; Clarke DS; Davies RD; Dossetter AG; Ertan A; Fenwick M; Green C; Holmes JL; Martin N; Masters D; Moore JE; Newcombe NJ; Newton C; Pointon H; Robb GR; Sheldon C; Stokes S; Morgan D
    J Med Chem; 2014 Jul; 57(14):6128-40. PubMed ID: 24967667
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of spirocyclic piperidine-azetidine inverse agonists of the ghrelin receptor.
    Kung DW; Coffey SB; Jones RM; Cabral S; Jiao W; Fichtner M; Carpino PA; Rose CR; Hank RF; Lopaze MG; Swartz R; Chen HT; Hendsch Z; Posner B; Wielis CF; Manning B; Dubins J; Stock IA; Varma S; Campbell M; DeBartola D; Kosa-Maines R; Steyn SJ; McClure KF
    Bioorg Med Chem Lett; 2012 Jul; 22(13):4281-7. PubMed ID: 22677316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ghrelin receptor: high constitutive activity and methods for developing inverse agonists.
    Els S; Beck-Sickinger AG; Chollet C
    Methods Enzymol; 2010; 485():103-21. PubMed ID: 21050913
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure-function studies on the new growth hormone-releasing peptide, ghrelin: minimal sequence of ghrelin necessary for activation of growth hormone secretagogue receptor 1a.
    Bednarek MA; Feighner SD; Pong SS; McKee KK; Hreniuk DL; Silva MV; Warren VA; Howard AD; Van Der Ploeg LH; Heck JV
    J Med Chem; 2000 Nov; 43(23):4370-6. PubMed ID: 11087562
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ghrelin--a novel generation of anti-obesity drug: design, pharmacomodulation and biological activity of ghrelin analogues.
    Chollet C; Meyer K; Beck-Sickinger AG
    J Pept Sci; 2009 Nov; 15(11):711-30. PubMed ID: 19787814
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential functional selectivity and downstream signaling bias of ghrelin receptor antagonists and inverse agonists.
    Ramirez VT; van Oeffelen WEPA; Torres-Fuentes C; Chruścicka B; Druelle C; Golubeva AV; van de Wouw M; Dinan TG; Cryan JF; Schellekens H
    FASEB J; 2019 Jan; 33(1):518-531. PubMed ID: 30020830
    [TBL] [Abstract][Full Text] [Related]  

  • 19. N-Terminal Liver-Expressed Antimicrobial Peptide 2 (LEAP2) Region Exhibits Inverse Agonist Activity toward the Ghrelin Receptor.
    M'Kadmi C; Cabral A; Barrile F; Giribaldi J; Cantel S; Damian M; Mary S; Denoyelle S; Dutertre S; Péraldi-Roux S; Neasta J; Oiry C; Banères JL; Marie J; Perello M; Fehrentz JA
    J Med Chem; 2019 Jan; 62(2):965-973. PubMed ID: 30543423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics and pharmacodynamics of PF-05190457: The first oral ghrelin receptor inverse agonist to be profiled in healthy subjects.
    Denney WS; Sonnenberg GE; Carvajal-Gonzalez S; Tuthill T; Jackson VM
    Br J Clin Pharmacol; 2017 Feb; 83(2):326-338. PubMed ID: 27621150
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.